Postbiotics are increasingly seen as an ideal focus for innovators in the world of microbiome modulation but hurdles are created by the lack of use of the word, by both consumers and the industry itself, according to industry experts at Probiota.
Future opportunities for probiotic innovation lie within combination ingredients, precision nutrition, and next-gen strains, according to Dr. Johanna Maukonon, director of global clinical innovation at IFF Health.
Berry researchers from around the world gathered last week at the 9th Biennial Berry Health Benefits Symposium in Tampa, FL to take a deep dive along the metabolic pathways in search of the microbes and metabolites that contribute to human health.
A scale-up company offering “the microbiome’s most powerful innovation platform” will attend NutraIngredients’ Probiota event next month (Feb 6-8) to showcase its pioneering technology to the gut health industry.
Calling all Probiotics, Prebiotics, and Microbiome start-ups!
Italian probiotics heavyweight Probiotical plans to bolster its presence in the US market by riding what the company calls a rising tide of consumer awareness of the importance of gut wellbeing to skin health.
Two senior leaders from probiotics heavyweights H&H Group, the owner of Swisse and Biostime among others, will be revealing the latest market trends and scientific developments in microbiome nutrition at our forthcoming Growth Asia Summit in Singapore.
NutraIngredients is on the hunt for entrepreneurial consumer-facing, science- or technology-based start-ups to join our Probiota community and present their company in Copenhagen. Do you have what it takes? If so, there are just a few days left to apply!
Consumers are increasingly aware of the detrimental effects of not getting enough sleep, and emerging links between the gut microbiota and sleep could create opportunities for prebiotics and probiotics in the booming natural sleep aid category.
Are you researching the latest state-of-the-art developments related to prebiotic, probiotic and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!
After a record-breaking 2020 Digital Summit, the IPA World Congress + Probiota Americas is back for 2021 with a dynamic extended program, a more immersive platform with new features, and more on-demand content.
With one week to go till Probiota, NutraIngredients took the opportunity to chat with one of the panellists for the event to hear his thoughts on where the industry is heading towards in the next few years.
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.